1-9 of 9
Phyllis McKiernan, APN, MSN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Autologous Stem Cell Transplantation in Very Elderly Patients with Multiple Myeloma

Phyllis McKiernan, APN, MSN, David Siegel, MD PhD, David H. Vesole, MD PhD, Scott D. Rowley, MD, Tracy Andrews, PhD, Andrea Ortega, RN, Alan P Skarbnik, MD, Noa Biran, MD, Joshua R Richter, MD, Andrew L. Pecora, MD, Andre Goy, MD, Rima M Panchal, MD, Nino Aleksidze, MD, Michele L. Donato, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2013.
https://doi.org/10.1182/blood.V130.Suppl_1.2013.2013
Published: 2017
Journal Articles

Patients Responding to Any First Line Therapy for Multiple Myeloma Should Proceed to Autologous Stem Cell Transplantation Instead of Receiving Second Line Therapy to Deepen Response

Nino Aleksidze, MD, Phyllis McKiernan, APN, MSN, David Siegel, MD PhD, Scott D. Rowley, MD, David H. Vesole, MD PhD, Tracy Andrews, PhD, Andrea Ortega, RN, Alan P Skarbnik, MD, Noa Biran, MD, Joshua R Richter, MD, Andrew L. Pecora, MD, Andre Goy, MD, Rima M Panchal, MD, Michele L. Donato, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4538.
https://doi.org/10.1182/blood.V130.Suppl_1.4538.4538
Published: 2017
Journal Articles

Day 90 Post-Allogeneic Hematopoietic Cell Transplantation T Cell Receptor Diversity Level Correlates with Risk of Relapse in Patients with Multiple Myeloma

Robert Korngold, PhD, Kira Goldgirsh, MS, Themba Nyirenda, PhD, Phyllis McKiernan, APN, MSN, Ryan Emerson, PhD, Marissa Vignali, PhD, Julie Rubinstein, Harlan Robins, PhD, David Siegel, MD PhD, Michele L. Donato, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4506.
https://doi.org/10.1182/blood.V130.Suppl_1.4506.4506
Published: 2017
Journal Articles

Cyclophosphamide Based Regimens Compared to Plerixafor-Based Regimens for Stem Cell Mobilization in Patients with Multiple Myeloma Result in Higher CD34+ Cell Yield, Lower Cost and Similar Outcome Post Autologous Transplantation

Rima M Panchal, MD, Phyllis McKiernan, APN, MSN, David Siegel, MD PhD, Scott D. Rowley, MD, David H. Vesole, MD PhD, Tracy Andrews, PhD, Andrea Ortega, RN, Alan P Skarbnik, MD, Noa Biran, MD, Joshua R Richter, MD, Nino Aleksidze, MD, Andrew L. Pecora, MD, Andre Goy, MD, Maribel Pereiras, Pharm D, Michele L. Donato, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3283.
https://doi.org/10.1182/blood.V130.Suppl_1.3283.3283
Published: 2017
Journal Articles

Risk of Engraftment Syndrome after Autologous Stem Cell Transplantation for Multiple Myeloma Increases with Age and Lower Dose of CD34+ Cells, but Is Not Impacted By Immunomodulatory Chemotherapy

Phyllis McKiernan, APN, MSN, David Siegel, MD PhD, Scott D. Rowley, MD, David H. Vesole, MD PhD, Tracy Andrews, PhD, Andrea Ortega, RN, Alan P Skarbnik, MD, Noa Biran, MD, Joshua R Richter, MD, Andrew L. Pecora, MD, Andre Goy, MD, Rima M Panchal, MD, Nino Aleksidze, MD, Michele L. Donato, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3284.
https://doi.org/10.1182/blood.V130.Suppl_1.3284.3284
Published: 2017
Journal Articles

Preliminary Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (I) and Nivolumab (N) As Consolidation Following Autologous Stem Cell Transplantation (ASCT) for High-Risk Hematologic Malignancies - Cpit-001 Trial

Alan P Skarbnik, MD, Michele L. Donato, MD, Scott D. Rowley, MD, Andre Goy, MD, David H. Vesole, MD, Pashna N. Munshi, MD, David Siegel, MD PhD, Noa Biran, MD, Joshua R Richter, MD, Tatyana A Feldman, MD, Lori A. Leslie, MD, Mary E Dilorenzo, APN, Phyllis McKiernan, APN, MSN, Melissa Baker, MSN, ANP, Michele Boonstra, APN, Michele Simone, APN, Ann McNeill, ANP, Ernest Richards, PhD, Joshua Zenreich, Mariefel Vendivil, RN, Andrea Ortega, RN, Jacquelyn Callahan, RN, Michael B Atkins, MD, Andrew L. Pecora, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 340.
https://doi.org/10.1182/blood.V130.Suppl_1.340.340
Published: 2017
Journal Articles

Long-Term Survival Is Demonstrated in Patients with Multiple Myeloma Treated with Allogeneic Hematopoietic Stem Cell Transplantation in Both the Consolidation and Salvage Settings

Phyllis McKiernan, APN, MSN, David S. Siegel, MD PhD, David H. Vesole, MD PhD, Tracy Andrews, MA, Scott D. Rowley, MD, Noa Biran, MD, Joshua R. Richter, MD, Andrew L. Pecora, MD, Alan P Skarbnik, MD, Andre Goy, MD, Michele L. Donato, MD
Journal: Blood
Blood (2016) 128 (22): 2302.
https://doi.org/10.1182/blood.V128.22.2302.2302
Published: 2016
Journal Articles

High Rate of Engraftment Syndrome in Elderly Patients with Multiple Myeloma Receiving Autologous Peripheral Blood Stem Cell Transplantation

Phyllis McKiernan, APN, MSN, OCN, David Siegel, MD PhD, David H. Vesole, MD, Themba Nyirenda, PhD, Scott D. Rowley, MD FACP, Alan P Skarbnik, MD, Ann Ferolin-Ocot, RN, BSN, OCN, Daniel Kim, Neil Shah, MD, Michele L. Donato, MD
Journal: Blood
Blood (2015) 126 (23): 3175.
https://doi.org/10.1182/blood.V126.23.3175.3175
Published: 2015
Journal Articles

Haploidentical Allogeneic Transplantation As Salvage in Relapsed Multiple Myeloma

Phyllis McKiernan, APN, MSN, David H. Vesole, MD PhD, David S. Siegel, MD PhD, Scott D Rowley, MD FACP, Melissa F Baker, APN, Brenda Diaz, APN, Themba Nyirenda, PhD, Joshua R. Richter, MD, Pamela Sutherland, APN, Michele L. Donato, MD
Journal: Blood
Blood (2014) 124 (21): 5918.
https://doi.org/10.1182/blood.V124.21.5918.5918
Published: 2014